CLDX earnings
Celldex Therapeutics (CLDX) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
CLDX earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | Aug 6, 2026 | -0.94 | -1.06 | 11.32% | $22.00K |
| Q1 2026 | May 7, 2026 | -1.18 | -1.15 | -2.86% | $15.00K |
| Q4 2025 | Feb 25, 2026 | -1.22 | -1.00 | -22.00% | $75.00K |
| Q3 2025 | Nov 10, 2025 | -1.01 | -0.88 | -14.77% | – |
| Q2 2025 | Aug 7, 2025 | -0.85 | -0.86 | 1.16% | $730.00K |
| Q1 2025 | May 8, 2025 | -0.81 | -0.75 | -8.00% | $695.00K |
| Q4 2024 | Feb 27, 2025 | -0.71 | -0.73 | 2.74% | $1.18M |
| Q3 2024 | Nov 5, 2024 | -0.64 | -0.69 | 7.25% | $3.19M |
| Q2 2024 | Aug 8, 2024 | -0.54 | -0.59 | 8.47% | $2.50M |
| Q1 2024 | May 5, 2024 | -0.56 | -0.67 | 16.42% | $156.00K |
| Q4 2023 | Feb 25, 2024 | -0.83 | -0.76 | -9.21% | $4.13M |
| Q3 2023 | Nov 2, 2023 | -0.81 | -0.67 | -20.90% | $1.52M |
| Aug 7, 2023 | -0.65 | -0.65 | 0.00% | – | |
| May 4, 2023 | -0.62 | -0.63 | 1.59% | – | |
| Feb 28, 2023 | -0.56 | -0.59 | 5.08% | – | |
| Nov 9, 2022 | -0.57 | -0.57 | 0.00% | – | |
| Aug 8, 2022 | -0.77 | -0.46 | -67.39% | – | |
| May 5, 2022 | -0.49 | -0.46 | -6.52% | – | |
| Feb 28, 2022 | -0.43 | -0.42 | -2.38% | – | |
| Nov 9, 2021 | -0.39 | -0.35 | -11.43% | – |
- CLDX reports next on Nov 9, 2026, with EPS of -1.04 expected.
- CLDX beat EPS estimates in 60 of its last 115 reports.
Updated 2026-11-03 11:32 UTC